ATE525077T1 - Pharmazeutische zusammensetzung enthaltend salpetersäure und einen zinksalz und entsprechende medizinische vorrichtung für die behandlung von hautläsionen - Google Patents

Pharmazeutische zusammensetzung enthaltend salpetersäure und einen zinksalz und entsprechende medizinische vorrichtung für die behandlung von hautläsionen

Info

Publication number
ATE525077T1
ATE525077T1 AT09151111T AT09151111T ATE525077T1 AT E525077 T1 ATE525077 T1 AT E525077T1 AT 09151111 T AT09151111 T AT 09151111T AT 09151111 T AT09151111 T AT 09151111T AT E525077 T1 ATE525077 T1 AT E525077T1
Authority
AT
Austria
Prior art keywords
nitric acid
composition
treatment
zinc
medical device
Prior art date
Application number
AT09151111T
Other languages
English (en)
Inventor
Alfred Marchal
Original Assignee
Auriga Internat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Auriga Internat filed Critical Auriga Internat
Application granted granted Critical
Publication of ATE525077T1 publication Critical patent/ATE525077T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/36Arsenic; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/12Keratolytics, e.g. wart or anti-corn preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
AT09151111T 2008-01-25 2009-01-22 Pharmazeutische zusammensetzung enthaltend salpetersäure und einen zinksalz und entsprechende medizinische vorrichtung für die behandlung von hautläsionen ATE525077T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08100943 2008-01-25

Publications (1)

Publication Number Publication Date
ATE525077T1 true ATE525077T1 (de) 2011-10-15

Family

ID=39522197

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09151111T ATE525077T1 (de) 2008-01-25 2009-01-22 Pharmazeutische zusammensetzung enthaltend salpetersäure und einen zinksalz und entsprechende medizinische vorrichtung für die behandlung von hautläsionen

Country Status (6)

Country Link
US (1) US20090191281A1 (de)
EP (1) EP2082744B1 (de)
AT (1) ATE525077T1 (de)
ES (1) ES2373772T3 (de)
PL (1) PL2082744T3 (de)
PT (1) PT2082744E (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11069773B2 (en) 2018-11-26 2021-07-20 Taiwan Semiconductor Manufacturing Co., Ltd. Contact-to-gate monitor pattern and fabrication thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH629100A5 (de) * 1979-09-27 1982-04-15 Solco Basel Ag Hautpraeparat.
MY128187A (en) 1993-06-23 2007-01-31 Icn Switzerland Ag Preparation for skin and mucous membrane
US5445462A (en) * 1993-08-03 1995-08-29 Medi-Flex Hospital Products, Inc. Liquid applicator
CA2358813A1 (en) * 2000-10-13 2002-04-13 Pedinol Pharmacal, Inc. Method for applying a medicament and swab applicator for uses therewith

Also Published As

Publication number Publication date
EP2082744B1 (de) 2011-09-21
PL2082744T3 (pl) 2012-02-29
ES2373772T3 (es) 2012-02-08
PT2082744E (pt) 2011-12-23
US20090191281A1 (en) 2009-07-30
EP2082744A1 (de) 2009-07-29

Similar Documents

Publication Publication Date Title
WO2002085386A3 (en) Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue
Kiguchi et al. Speciation of arsenic trioxide penetrates into cerebrospinal fluid in patients with acute promyelocytic leukemia
ATE476972T1 (de) Verwendung von valproinsäure zur topischen behandlung von leichter bis mittelschwerer akne vulgaris
RU2006140864A (ru) Фармацевтические композиции на основе лишайника бородатого (usnea barbata) и зверобоя обыкновенного (hypericum perforatum) и их применение
MX2023009856A (es) Dosificacion optimizada de diaminofenotiazinas en poblaciones.
Cappelletti et al. Mercuric chloride poisoning: symptoms, analysis, therapies, and autoptic findings. A review of the literature
Guo et al. Serum and testicular testosterone and nitric oxide products in aluminum-treated mice
CN102861102A (zh) 一种纳米银抑菌喷剂
EP2592052A1 (de) Anolyt, Verfahren zu dessen Herstellung und dessen Verwendung
CN102204880A (zh) 一种妇科外用消毒液凝胶剂及其制备方法
EP3158990B1 (de) Formulierung zur freisetzung von stickoxid
ATE525077T1 (de) Pharmazeutische zusammensetzung enthaltend salpetersäure und einen zinksalz und entsprechende medizinische vorrichtung für die behandlung von hautläsionen
CN101263812A (zh) 一种杀菌消毒剂及制备方法
CN105848624B (zh) 浸渍装置
CN103508911B (zh) 一种消杀剂的合成方法
GB2529597A (en) An oxychlorine oral rinse composition
Tubafard et al. Chelation of bismuth by combining desferrioxamine and deferiprone in rats
TW200716192A (en) Use of adamantyl methoxydiphenyl propenoic acid for the treatment of dermatological diseases
CN103446399B (zh) 一种治疗痤疮的外用中药面膜制剂及其制造工艺
CN102846661B (zh) 一种复方纳米银乳膏及其制备方法
US20100099758A1 (en) Regenerative wound healing using copper-silver citrate composition
Tiwari et al. Chemo-Therapeutic management of foot abscess in female Asian Elephant (Elephas maximus)
Tapke et al. Agriculture and therapeutic uses of cow urine
JP3519991B2 (ja) 中性銀イオン水の製造方法
UA130470U (uk) Спосіб комплексного лікування вугрової хвороби

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2082744

Country of ref document: EP